Last reviewed · How we verify
aloevera juice
aloevera juice is a Small molecule drug developed by The Oxford Dental College, Hospital and Research Center, Bangalore, India. It is currently in Phase 3 development for Oral mucositis prevention and treatment.
Aloevera juice has anti-inflammatory and antioxidant properties that may help soothe and protect oral tissues.
Aloe vera juice has been studied as a potential treatment for Oral Submucous Fibrosis, a condition that has been the subject of a completed clinical trial. The exact mechanism by which aloe vera juice may exert its effects is currently unknown.
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | aloevera juice |
|---|---|
| Sponsor | The Oxford Dental College, Hospital and Research Center, Bangalore, India |
| Modality | Small molecule |
| Therapeutic area | Dental |
| Phase | Phase 3 |
Mechanism of action
The exact molecular targets of aloevera juice are not well understood, but its anti-inflammatory and antioxidant effects are thought to be mediated by various bioactive compounds, including vitamins, minerals, and polyphenols. These compounds may help reduce inflammation and oxidative stress in the oral cavity, promoting healing and tissue protection.
Approved indications
- Oral mucositis prevention and treatment
Common side effects
- Gastrointestinal upset
Key clinical trials
- Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- aloevera juice CI brief — competitive landscape report
- aloevera juice updates RSS · CI watch RSS
- The Oxford Dental College, Hospital and Research Center, Bangalore, India portfolio CI
Frequently asked questions about aloevera juice
What is aloevera juice?
How does aloevera juice work?
What is aloevera juice used for?
Who makes aloevera juice?
What development phase is aloevera juice in?
What are the side effects of aloevera juice?
Related
- Manufacturer: The Oxford Dental College, Hospital and Research Center, Bangalore, India — full pipeline
- Therapeutic area: All drugs in Dental
- Indication: Drugs for Oral mucositis prevention and treatment
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing